BridgeMD
New treatment option for Healthy
Official title Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity
ClinicalTrials.gov ID: NCT07715955
What this study is testing
- What it's testing
- The goal of this 16-week randomised, placebo-controlled parallel study is to investigate the effect of a newly formed probiotic supplement on satiety and gut microbiota composition in healthy men and women with overweight or obesity form 20-70 years old. The main question it aims to answer is: Does the probiotic supplement increase feelings of satiety and alter gut microbiota composition?
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Men and women, aged between 20-70 years
- BMI ³ 25 kg/m2
- Stable body weight (weight gain or loss \< 3 kg in the past three months)
- Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
- No difficult venipuncture as evidenced during the screening visit
You likely can't join if
- Diabetic patients (type 1 and type 2)
- Abuse of drugs
- More than 2 units alcoholic consumptions per day for women and 3 for men
- Use of products or dietary supplements known to interfere with the main outcomes 3 months prior to the start of the study as judged by the principal...
- Gastrointestinal disease (including IBD and IBS)
- Use of an investigational product within another biomedical intervention trial within the previous 1-month
See the full eligibility criteria
- Men and women, aged between 20-70 years
- BMI ³ 25 kg/m2
- Stable body weight (weight gain or loss \< 3 kg in the past three months)
- Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
- No difficult venipuncture as evidenced during the screening visit
- Diabetic patients (type 1 and type 2)
- Abuse of drugs
- More than 2 units alcoholic consumptions per day for women and 3 for men
- Use of products or dietary supplements known to interfere with the main outcomes 3 months prior to the start of the study as judged by the principal investigators
- Gastrointestinal disease (including IBD and IBS)
- Use of an investigational product within another biomedical intervention trial within the previous 1-month
- Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, autoimmune disease and rheumatoid arthritis
- Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident
- use of lipid- and glucose lowering medication, corticosteroid use
- Psychiatric diagnoses including clinical depression
- Intolerances or dietary habits that might interfere with the study (i.e. lactose intolerance or veganism)
- pregnancy
- smoking, vaping
- use of antibiotics up to 3 months prior to the study
The study team makes the final eligibility decision.
Where it's taking place
- Maastricht, Limburg, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maastricht, Limburg, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.